Medical prevention of stroke, 2003

被引:10
作者
Kirshner, HS [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA
关键词
ACETYLSALICYLIC-ACID; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; RISK-FACTOR; STATINS; DISEASE; INTERVENTION; CONSUMPTION; PRAVASTATIN; MORTALITY;
D O I
10.1097/01.SMJ.0000063469.77850.08
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stroke is a preventable tragedy for nearly 750,000 people each year. Primary stroke prevention measures applicable to the general public include a healthy diet containing fruits, vegetables, fish, and low fat; exercise; smoking cessation; limiting alcohol to moderate use; and perhaps avoidance of stress. Screening for hypertension, cholesterol, heart disease, and carotid artery stenosis can lead to even more effective stroke prevention in high-risk patients. Specific antihypertensive drugs such as angiotensin-converting enzyme inhibitors and angiotensin-converting enzyme receptor blockers may be especially protective against stroke. Secondary stroke prevention in patients who have already had a stroke or transient ischemic attack is even more effective in preventing more serious strokes. Measures include antihypertensive and cholesterol-lowering agents, carotid endarterectomy, anticoagulation for atrial fibrillation and other cardiac sources of embolic stroke, and antiplatelet therapy. Stroke prevention depends on the application of these well-known and widely available treatments to a large number of patients.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 50 条
[11]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[12]  
CUPPLES A, 1987, DHHS PUBL
[13]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[14]   European stroke prevention study .2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [J].
Diener, HC ;
Cunha, L ;
Forbes, C ;
Sivenius, J ;
Smets, P ;
Lowenthal, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :1-13
[15]  
FURBERG CD, 2002, JAMA-J AM MED ASSOC, V288
[16]   A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].
Gent, M ;
Beaumont, D ;
Blanchard, J ;
Bousser, MG ;
Coffman, J ;
Easton, JD ;
Hampton, JR ;
Harker, LA ;
Janzon, L ;
Kusmierek, JJE ;
Panak, E ;
Roberts, RS ;
Shannon, JS ;
Sicurella, J ;
Tognoni, G ;
Topol, EJ ;
Verstraete, M ;
Warlow, C .
LANCET, 1996, 348 (9038) :1329-1339
[17]   Prevention of a first stroke - A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association [J].
Gorelick, PB ;
Sacco, RL ;
Smith, DB ;
Alberts, M ;
Mustone-Alexander, L ;
Rader, D ;
Ross, JL ;
Raps, E ;
Ozer, MN ;
Brass, LM ;
Malone, ME ;
Goldberg, S ;
Booss, J ;
Hanley, DF ;
Toole, JF ;
Greewold, NL ;
Rhew, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (12) :1112-1120
[18]   A RANDOMIZED TRIAL COMPARING TICLOPIDINE HYDROCHLORIDE WITH ASPIRIN FOR THE PREVENTION OF STROKE IN HIGH-RISK PATIENTS [J].
HASS, WK ;
EASTON, JD ;
ADAMS, HP ;
PRYSEPHILLIPS, W ;
MOLONY, BA ;
ANDERSON, S ;
KAMM, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (08) :501-507
[19]   FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135
[20]   Physical activity and risk of stroke in women [J].
Hu, FB ;
Stampfer, MJ ;
Colditz, GA ;
Ascherio, A ;
Rexrode, KM ;
Willett, WC ;
Manson, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (22) :2961-+